£45.55

Springer Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune: 157 (Falk Symposium, 157)

Price data last checked 34 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£46 today · usual range £38–£48 · best ever £38

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 57 days • 57 data points (No recent data available)

Historical
Generating forecast...
£47.57 £36.97 £39.28 £41.59 £43.91 £46.22 £48.53 24 March 2026 07 April 2026 21 April 2026 05 May 2026 19 May 2026

Price Distribution

Price distribution over 57 days • 3 price levels

Days at Price
Current Price
14 days 22 days 21 days 0 6 11 17 22 £38 £46 £48 Days at Price

Price Analysis

Most common price: £46 (22 days, 38.6%)

Price range: £38 - £48

Price levels: 3 different prices over 57 days

Description

This book is the proceedings of Falk Symposium 157, entitled ‘Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune’, held in Freiburg, Germany, on 10--11 October 2006 (one of three symposia during the XIII Falk Liver Week 2006). It provides up-to-date information on new developments in the field of chronic hepatitis and its various entities. In recent decades we have learned how heterogeneous the clinical entity of chronic hepatitis has become. The liver, as the central organ of metabolism and detoxification, is more than ever a target of disease processes evolving from the spread of obesity in the western world. Apart from nonalcoholic steatohepatitis (NASH), alcoholic liver disease is still the most prevalent liver disease in the west. Alcohol-induced liver disease exhibits a broad clinical spectrum from alcoholic steatohepatitis to cirrhosis. Alcoholic hepatitis is a disease entity with a particular poor prognosis. Any liver disease of unknown cause is suspected as being drug-associated. Every new drug metabolized in the liver has the potential to damage the liver. Primary biliary cirrhosis has seen significant progress due to the identification of new risk factors based on new epidemiological studies. Interface hepatitis has become a prognostic marker as well as a therapeutic target. The treatment of autoimmune hepatitis has progressed significantly due to an individualized approach to immunosuppression.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
21 August 2007
Listed Since
06 July 2007

Barcode

No barcode data available

Similar Products You Might Like

Liver Cirrhosis: From Pathophysiology to Disease Management: 162 (Falk Symposium, 162)
86% match

Liver Cirrhosis: From Pathophysiology to Disease Management: 162 (Falk Symposium, 162)

Springer

£76.92 11 Jun 2026
Acute and Chronic Liver Diseases: Molecular Biology and Clinics: 87 (Falk Symposium, 87)
86% match

Acute and Chronic Liver Diseases: Molecular Biology and Clinics: 87 (Falk Symposium, 87)

Springer

£24.00 05 Jun 2026
Immunology and Liver: 114 (Falk Symposium)
85% match

Immunology and Liver: 114 (Falk Symposium)

Springer

£121.51 30 May 2026
Hepatitis B Virus and Liver Disease
83% match

Hepatitis B Virus and Liver Disease

Springer

£89.12 05 Jun 2026
Steatohepatitis (NASH and ASH): 121 (Falk Symposium, 121)
82% match

Steatohepatitis (NASH and ASH): 121 (Falk Symposium, 121)

Springer

£142.11 05 Jun 2026
Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside
82% match

Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside

Springer

£62.75 05 Jun 2026
Hepatic Metabolism and Disposition of Endo- and Xenobiotics: 57 (Falk Symposium, 57)
81% match

Hepatic Metabolism and Disposition of Endo- and Xenobiotics: 57 (Falk Symposium, 57)

Springer

£79.00 01 Jun 2026
Hepatitis Prevention and Treatment (Milestones in Drug Therapy)
81% match

Hepatitis Prevention and Treatment (Milestones in Drug Therapy)

Birkhauser

£117.20 23 May 2026
Praxis der Hepatologie
80% match

Praxis der Hepatologie

Springer

£66.52 05 Jun 2026
Hepatitis Prevention and Treatment (Milestones in Drug Therapy)
80% match

Hepatitis Prevention and Treatment (Milestones in Drug Therapy)

Birkhauser

£108.16 24 May 2026
Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma
80% match

Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma

Springer

£77.75 22 May 2026
Non-Alcoholic Fatty Liver Disease Research 2016
80% match

Non-Alcoholic Fatty Liver Disease Research 2016

MDPI AG

£80.84 14 Jun 2026
Hepatic Critical Care
80% match

Hepatic Critical Care

Springer

£117.77 05 Jun 2026
Autoimmune Liver Disease: Management and Clinical Practice
80% match

Autoimmune Liver Disease: Management and Clinical Practice

Wiley-Blackwell

£104.41 14 May 2026
Precision Molecular Pathology of Liver Cancer (Molecular Pathology Library)
79% match

Precision Molecular Pathology of Liver Cancer (Molecular Pathology Library)

Springer

£71.94 06 Jun 2026
Hepadnaviruses: Molecular Biology and Pathogenesis: 168 (Current Topics in Microbiology and Immunology, 168)
79% match

Hepadnaviruses: Molecular Biology and Pathogenesis: 168 (Current Topics in Microbiology and Immunology, 168)

Springer

£74.12 31 May 2026
Hepatitis C Virus and Liver Transplantation
79% match

Hepatitis C Virus and Liver Transplantation

Springer

£73.10 31 May 2026
Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism: 67 (Subcellular Biochemistry, 67)
79% match

Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism: 67 (Subcellular Biochemistry, 67)

Springer

£107.98 25 May 2026
Liver Cirrhosis: Causes, Diagnosis & Treatment (Hepatology Research and Clinical Developments)
78% match

Liver Cirrhosis: Causes, Diagnosis & Treatment (Hepatology Research and Clinical Developments)

£147.99 05 Jun 2026
HIV and Liver Disease
78% match

HIV and Liver Disease

Springer

£80.64 25 May 2026
Induction and Modulation of Gastrointestinal Inflammation: 104 (Falk Symposium, 104)
78% match

Induction and Modulation of Gastrointestinal Inflammation: 104 (Falk Symposium, 104)

Springer

£24.00 24 May 2026
Non-Neoplastic Liver Pathology: A Pathologist’s Survival Guide
78% match

Non-Neoplastic Liver Pathology: A Pathologist’s Survival Guide

Springer

£91.92 05 Jun 2026
Stem Cell and Liver Regeneration (Frontiers in Hepatology)
78% match

Stem Cell and Liver Regeneration (Frontiers in Hepatology)

Springer

£85.58 08 Jun 2026
Stem Cell and Liver Regeneration
78% match

Stem Cell and Liver Regeneration

Springer

£77.24 20 May 2026